At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Cholecalciferol +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Placebo Controlled Trial of Vitamin D Therapy in Patients With Heart Failure
In Brief
A clinical study evaluating Cholecalciferol for Heart Failure. Completed, enrolled 64 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if vitamin D will improve physical performance in older adults with heart failure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedMay 2010
Primary CompletionSep 2011
TodayJul 2026
First PostedMay 18, 2010
Enrollment StartJul 1, 2008
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 16.1 years ago
Interventions
Cholecalciferoldietary
50,000 units of oral vitamin D3(cholecalciferol) weekly plus 800 calcium daily
Cholecalciferoldietary
Weekly placebo plus 800 calcium alone